Indian Journal of Rheumatology

REVIEW ARTICLE
Year
: 2020  |  Volume : 15  |  Issue : 5  |  Page : 45--51

Psoriatic arthritis: An up to date overview


Simon Hackett, Laura Coates 
 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England, UK

Correspondence Address:
Dr. Laura Coates
NIHR Clinician Scientist, Botnar Research Centre, Windmill Road, Oxford OX2 8DG, England
UK

Psoriatic arthritis (PsA) is a chronic, systemic inflammatory arthritis with symptoms spanning six domains including peripheral arthritis, enthesitis, dactylitis, axial disease, psoriasis, and nail disease. The classification of disease has been refined over recent years following the development of criteria such as ClASsification of PsA criteria. In addition to classification, treatment options for PsA have continued to expand over recent years, with the development of monoclonal antibody therapies targeting the underlying immunological mediators involved in PsA such as interleukin (IL)-17, tumor necrosis factor-alpha, and IL-23. Therapies have shown that robust treatment in patients, achieving tight disease control, improves outcomes and overall quality of life. This review provides a broad overview of the epidemiology, classification, and treatment of PsA.


How to cite this article:
Hackett S, Coates L. Psoriatic arthritis: An up to date overview.Indian J Rheumatol 2020;15:45-51


How to cite this URL:
Hackett S, Coates L. Psoriatic arthritis: An up to date overview. Indian J Rheumatol [serial online] 2020 [cited 2022 Jan 16 ];15:45-51
Available from: https://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=5;spage=45;epage=51;aulast=Hackett;type=0